Balance of convenience in public health matters

Introduction

The balance of convenience is an important judicial principle applied by courts while deciding applications for temporary injunctions and interim relief. It requires the court to compare the potential hardship, injury and consequences that may arise if interim relief is granted against those that may arise if such relief is refused.

In public health matters, this principle assumes particular importance because judicial decisions can affect the health, safety and welfare of large sections of society. Public health disputes may involve pharmaceutical products, clinical trials, biotechnology research, environmental pollution, medical facilities, vaccine distribution, infectious disease control and the regulation of hazardous biological materials.

Courts must therefore balance individual rights, commercial interests, scientific development and the collective interest of society. For example, when a pharmaceutical company challenges a government restriction on a particular medicine, the court must consider not only the company's financial interests but also the possible consequences for patients and public health.

The balance of convenience is not determined merely by identifying which party may suffer greater financial loss. Courts also consider public interest, scientific evidence, potential health risks, statutory obligations and the possibility of irreversible harm.

Meaning and legal principles of balance of convenience

Balance of convenience refers to the comparative assessment of hardship and inconvenience likely to be suffered by the parties if an interim order is granted or refused.

In civil litigation, courts generally examine three essential conditions before granting temporary injunctions:

Prima facie case: Whether the applicant has presented a genuine legal issue requiring judicial consideration.

Balance of convenience: Whether the comparative hardship favours granting the requested interim relief.

Irreparable injury: Whether refusal of interim protection may cause injury that cannot adequately be compensated through monetary damages.

These principles are particularly significant in public health litigation because an interim order may affect thousands or millions of individuals.

For example, if a company seeks an injunction against a government order restricting a potentially unsafe pharmaceutical product, the court must evaluate the consequences of allowing continued distribution against the commercial losses resulting from the restriction.

The court may refuse interim relief if granting it would expose the public to serious health risks, even where the applicant establishes a substantial commercial interest.

Legal framework governing balance of convenience in India

1. Code of Civil Procedure, 1908

The Code of Civil Procedure, 1908 provides the principal procedural framework for temporary injunctions.

Order XXXIX Rule 1 permits courts to grant temporary injunctions in specified circumstances, including situations where property or other legally protected interests are at risk.

Order XXXIX Rule 2 provides for injunctions restraining the continuation or repetition of certain breaches or injuries.

Section 94 also recognises the court's power to grant temporary injunctions and other interlocutory orders.

In public health disputes, these provisions may be relevant where an applicant seeks interim protection against activities allegedly involving unsafe medicines, hazardous substances or unlawful commercial practices.

2. Constitution of India

The constitutional framework provides substantial support for balancing individual interests with public health protection.

Article 21: Protects the right to life and personal liberty. The Supreme Court has interpreted this provision to include the right to health and access to essential medical facilities.

Article 14: Guarantees equality before the law and protection against arbitrary state action.

Article 19(1)(g): Protects the right to practise any profession or carry on any occupation, trade or business, subject to reasonable restrictions under Article 19(6).

Article 47: Directs the State to regard the improvement of public health as among its primary duties.

Article 48A: Directs the State to protect and improve the environment, which is closely connected with public health.

These provisions require courts to consider both individual freedoms and the constitutional responsibility of the State to protect public welfare.

3. Drugs and Cosmetics Act, 1940

The Drugs and Cosmetics Act, 1940 regulates the import, manufacture, distribution and sale of drugs and cosmetics in India.

The legislation establishes quality-control requirements and regulatory mechanisms to protect consumers from unsafe, misbranded, adulterated and spurious drugs.

When pharmaceutical companies challenge regulatory restrictions, courts may examine whether interim relief would undermine the statutory objective of protecting public health.

4. Environment (Protection) Act, 1986

The Environment (Protection) Act, 1986 provides the legal foundation for environmental protection and control of activities that may adversely affect human health and the environment.

In disputes involving hazardous industrial activities, biotechnology facilities and environmental contamination, courts may consider public health consequences while determining whether interim injunctions should be granted.

Important judicial decisions and case laws

1. Wander Ltd. v. Antox India P. Ltd. (1990)

This is an important Supreme Court decision concerning the principles governing temporary injunctions and appellate interference with discretionary judicial orders.

The Court explained that granting an interim injunction involves the exercise of judicial discretion and that appellate courts should generally avoid interfering unless the discretion has been exercised arbitrarily, perversely or contrary to established legal principles.

Relevance to public health: The principles are applicable where pharmaceutical or biotechnology companies seek interim injunctions against regulatory actions. Courts must carefully evaluate the competing interests and the consequences of granting or refusing temporary protection.

2. M.C. Mehta v. Union of India (1986)

This landmark litigation arose from the leakage of oleum gas from an industrial establishment in Delhi.

The Supreme Court developed the principle of absolute liability for enterprises engaged in hazardous or inherently dangerous activities.

The judgment established that enterprises conducting hazardous activities have a stringent responsibility to ensure that their operations do not harm members of the public.

Relevance to public health: The decision demonstrates that public safety may take priority over commercial interests where industrial or scientific activities create serious risks to human health. Courts considering interim relief in hazardous biotechnology or pharmaceutical activities may therefore give substantial weight to public protection.

3. Vincent Panikurlangara v. Union of India (1987)

The Supreme Court examined issues concerning the availability and regulation of drugs in India.

The judgment recognised the importance of protecting public health and ensuring that medicines available to the population meet appropriate safety and regulatory standards.

Relevance to public health: It supports the principle that the availability of safe and effective medicines is an important public interest. In disputes involving restrictions on pharmaceutical products, courts must consider the health consequences for patients alongside commercial interests.

4. Paschim Banga Khet Mazdoor Samity v. State of West Bengal (1996)

The Supreme Court considered the failure of government hospitals to provide timely medical treatment to an injured individual.

The Court held that the State has a constitutional obligation under Article 21 to provide adequate medical facilities and ensure that medical treatment is not denied because of administrative deficiencies.

Relevance to public health: The judgment demonstrates that public health considerations extend beyond individual disputes. When determining interim relief, courts must consider whether an order could interfere with access to essential healthcare facilities.

5. Consumer Education and Research Centre v. Union of India (1995)

The Supreme Court examined occupational health concerns involving workers exposed to hazardous asbestos-related conditions.

The Court recognised that the right to health and medical protection forms an important component of Article 21.

Relevance to public health: The decision supports the importance of preventive healthcare, occupational safety and protection against hazardous exposure. Courts may consider these interests when deciding whether industrial or commercial activities should continue during pending litigation.

6. A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999)

The Supreme Court discussed the importance of scientific expertise in environmental decision-making and recognised the precautionary principle in situations involving scientific uncertainty.

The judgment emphasised that decisions involving environmental and public health risks should take scientific knowledge and expert assessment into account.

Relevance to public health: In disputes concerning genetically modified organisms, pharmaceutical manufacturing, biological research and hazardous substances, courts may consider scientific uncertainty and potential consequences before granting interim relief.

Application of balance of convenience in biotechnology and public health disputes

The principle has particular significance in biotechnology because scientific developments may create both public benefits and potential health risks.

1. Pharmaceutical product regulation

When a pharmaceutical company challenges a government restriction on a medicine, courts must examine the safety evidence, regulatory requirements and consequences for patients.

The commercial interests of manufacturers cannot automatically outweigh the public's interest in access to safe medicines.

2. Clinical trials

In disputes involving clinical research, courts must consider participant safety, informed consent, ethical approval and the scientific importance of the research.

An interim order allowing an unsafe or improperly authorised trial may create serious public health concerns.

3. Genetically modified organisms

Disputes concerning genetically modified crops or biological materials may involve environmental and public health considerations.

Courts should examine biosafety assessments, regulatory approvals, scientific uncertainty and potential effects on affected communities.

4. Public vaccination programmes

Challenges to vaccine-related regulatory decisions require consideration of public safety, scientific evidence and the continuity of essential immunisation programmes.

Courts must evaluate whether granting interim relief could interfere with public health objectives.

5. Environmental and industrial biotechnology

Where biotechnology facilities involve potentially hazardous biological materials, courts may consider containment systems, regulatory compliance and risks to surrounding communities.

Factors considered by courts while determining balance of convenience

Courts generally examine the following considerations:

The seriousness and probability of potential public health risks.

The strength of the applicant's legal claim.

The availability of scientific and medical evidence.

The possibility of irreversible injury.

The constitutional right to health under Article 21.

The statutory responsibilities of regulatory authorities.

The economic consequences for the parties.

The impact of the proposed order on vulnerable communities.

The availability of alternative protective measures.

The broader public interest in granting or refusing interim relief.

An important consideration is that public interest is not automatically established merely because a party describes its commercial activity as beneficial to society. Courts must examine the actual evidence and statutory framework.

Conclusion

The balance of convenience in public health matters is an essential judicial principle for resolving conflicts between individual rights, commercial interests and collective welfare. Courts must ensure that interim relief does not expose the public to serious health risks or interfere unnecessarily with essential healthcare services.

Indian constitutional provisions, particularly Articles 14, 19 and 21, together with the Code of Civil Procedure, 1908, Drugs and Cosmetics Act, 1940 and Environment (Protection) Act, 1986, provide the legal foundation for applying this principle.

Judicial decisions such as Wander Ltd. v. Antox India P. Ltd., M.C. Mehta v. Union of India and Paschim Banga Khet Mazdoor Samity v. State of West Bengal demonstrate the importance of judicial discretion, environmental responsibility and the constitutional right to healthcare.

Ultimately, the balance of convenience in public health litigation requires courts to adopt an evidence-based and precautionary approach while ensuring that individual legal rights are protected without compromising the health, safety and welfare of society.